Connor, Clark & Lunn Investment Management (CC&L)’s Agios Pharmaceuticals AGIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.2M	Sell	450,093 -112,549	-20%	-$3.19M	0.04%	376
2025 Q4	$15.3M	Buy	562,642 +32,544	+6%	+$1.14M	0.04%	348
2025 Q3	$21.3M	Buy	530,098 +24,873	+5%	+$936K	0.07%	254
2025 Q2	$16.8M	Buy	505,225 +118,702	+31%	+$3.6M	0.06%	279
2025 Q1	$11.3M	Buy	386,523 +260,845	+208%	+$8.65M	0.05%	296
2024 Q4	$4.13M	Buy	125,678 +103,405	+464%	+$4.86M	0.02%	531
2024 Q3	$990K	Sell	22,273 -15,008	-40%	-$682K	﹤0.01%	893
2024 Q2	$1.61M	Buy	+37,281	New	+$1.35M	0.01%	715
2024 Q1	–	Sell	-10,131	Closed	-$226K	–	1505
2023 Q4	$226K	Buy	+10,131	New	+$227K	﹤0.01%	1241
2023 Q3	–	Sell	-80,083	Closed	-$2.27M	–	1341
2023 Q2	$2.27M	Sell	80,083 -42,451	-35%	-$1.06M	0.01%	578
2023 Q1	$2.81M	Sell	122,534 -29,608	-19%	-$786K	0.02%	483
2022 Q4	$4.27M	Sell	152,142 -41,333	-21%	-$1.16M	0.02%	383
2022 Q3	$5.47M	Buy	193,475 +51,820	+37%	+$1.39M	0.04%	310
2022 Q2	$3.14M	Buy	141,655 +32,767	+30%	+$740K	0.02%	399
2022 Q1	$3.17M	Buy	108,888 +23,410	+27%	+$715K	0.02%	402
2021 Q4	$2.81M	Sell	85,478 -18,645	-18%	-$750K	0.01%	455
2021 Q3	$4.8M	Buy	104,123 +77,943	+298%	+$3.77M	0.03%	347
2021 Q2	$1.44M	Buy	26,180 +17,616	+206%	+$985K	0.01%	610
2021 Q1	$442K	Buy	+8,564	New	+$424K	﹤0.01%	807